NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/18/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization673.9 mln
Float66.53 mln
Earnings Date08/06/2026
EPS
2.17
Solid
P / E
4.00
Deeply undervalued
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
12.48
Highly suspicious
1-Year Forecast
15.20
Transformational upside
Relative Strength
74
/ 100
Outperforming
Business Description
CorMedix is a New Jersey-based medical company working to protect seriously ill patients from dangerous infections. Its flagship product, DefenCath, is a solution used to clean and seal dialysis catheters, helping to prevent life-threatening bloodstream infections in people with kidney failure. The company has been operating under its current name since 2007.
